Ministry of Education
Kapil Kumar
VIDWAN ID: 522063

Dr Kapil Kumar

Male Doctor of Philosophy
Associate Professor | Department of Pharmaceutical Sciences
University of Petroleum and Energy Studies
Uttar Pradesh
Expertise: Medicinal Chemistry
ORCID 0000-0003-2875-2119 Scopus 26321638600 ResearcherID ABC-3733-2020 Google Scholar 6vBOqAMAAAAJ
View older version My Dashboard
55 Publications
4 Projects
1899 Scopus Citations
1771 CrossRef
11 Years 1 Month Total Experience
Publications
55 Total
Articles
53
Chapters
2
Activity

No publication activity to display.

Scopus Scopus
1,899 Citations
23 h-index
CrossRef CrossRef
1,771 Citations
22 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

Top 2% scientist
2024
Stanford University USA and Elsevier database
Top 2% scientist
2025
Stanford University, USA

Community & Membership

No Data Found

There is currently nothing to display here.

Association of Pharmaceutical Teachers of India
Life member
Jan 2019

Personal Details

Doctor of Philosophy
2015
SYMBIOSIS Institute of Technology, Pune
Master of Surgery
2012
SYMBIOSIS Institute of Technology, Pune
Bachelor of Pharmacy
2010
Sasurie College of Engineering
Associate Professor
Jan 2024 – Present
University of Petroleum and Energy Studies | Department of Pharmaceutical Sciences
Associate Professor
Mar 2022 – Jan 2024
Apeejay Stya University, Sohna
Assistant Professor
Jul 2019 – Mar 2022
SVKMS NARSEE MONJEE INSTITUTE OF MANAGEMENT STUDIES
Assistant Professor
Feb 2017 – Jul 2019
Apeejay Stya University, Sohna
Associate Professor
Aug 2015 – Feb 2017
Unknown Organization
Medical and Health Sciences
Medicinal Chemistry

Related Profiles

Scholarly Work

Development of Oxindole Based MELK Inhibitors for the Treatment of Triple Negative Breast Cancer
Other
Role: Principal Investigator
Amount: ₹5 Lac
Duration: 2025 – Ongoing
Development of Cellulose Based Enteric Polymers from Banana Peel Waste for Targeted Colorectal Cancer: A Sustainable to Pharmaceutical Innovation
Other
Role: Principal Investigator
Amount: ₹50,000
Duration: 2025 – Ongoing
Waste to best: Conversion of Krishi Avashesh (agriculture waste) to pharmaceutical excipients and their biomedical and technical applications
Other
Role: Principal Investigator Grant: HSCSIT/R&D/2022/2976
Amount: ₹17 Lac
Duration: 2022 – Ongoing
Development of diversified tryptanthrin derivatives as antioxidant agents
Completed
Role: Principal Investigator Grant: ASU/R/2022/290C
Amount: ₹3.20 Lac
Duration: 2022 – 2023

Design, Synthesis, and Evaluation of Fused Quinazoline Derivatives as Anticancer Agents

University Marwadi University, Rajkot, Gujrat
Year 2025
Downloads 0

Novel Hybrid Tryptanthrin Method Based Topoisomerase Inhibitors

Apeejay Styaq University
- Application No. : 202211031057 Filed : 11-05-2022
Published : 10-06-2022 Published

Polysubstituted Pyrrole Derivatives and Method of Synthesis Thereof

Apeejay Styaq University
- Application No. : 202211024651 Filed : 21-04-2022
Published : 06-05-2022 Published

Scholarly Publications

CuI/DBU-Mediated MBH Reaction of Isatins: A Convenient Synthesis of 3-Substituted-3-hydroxy-2-oxindole

Journal Article
CHEMISTRYSELECT. Year: 2020. Volume: 5 , Issue: 10 , Pages: 3048-3051 .
Authors: Kapil Kumar; Ravindra K. Rawal
DOI 10.1002/slct.201903703 Crossref Crossref: 19 Scopus Scopus: 20

Synthetic and medicinal perspective of fused-thiazoles as anticancer agents

Review
Anti-Cancer Agents in Medicinal Chemistry. Year: 2021. Volume: 21 , Issue: 11 , Pages: 1379-1402 .
Authors: Swati Pawar; Kapil Kumar; Manish K. Gupta; Ravindra K. Rawal
DOI 10.2174/1871520620666200728133017 Crossref Crossref: 42 Scopus Scopus: 45

Utilizing and Separating Cellulose and its Derivatives from Substantial Agricultural waste based on their Pharmaceutical and Physiochemical Evaluation

Journal Article
Research Journal of Pharmacy and Technology. Year: 2026. Volume: 19 , Issue: 3 , Pages: 1191-1198 .
Authors: Manoj Kumar Sharma; Narender Yadav; Jyoti Malik; Mukesh Kumar Kumawat; Kapil Kumar; Ritu Dahiya
DOI 10.52711/0974-360X.2026.00170

Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study

Journal Article
Toxicology in Vitro. Year: 2023. Volume: 86 .
Authors: Sachin Puri; Iqrar Ahmad; Harun Patel; Kapil Kumar; Kapil Juvale
DOI 10.1016/j.tiv.2022.105517 Crossref Crossref: 30 Scopus Scopus: 33

Anticancer properties of spirooxindole derivatives

Book Chapter
Year: 2024. Pages: 333-367 .
Authors: Kumawat, M.K.; Yadav, N.; Kumar, K.
DOI 10.1016/B978-0-443-22324-2.00013-8 Crossref Crossref: 2 Scopus Scopus: 5

Microwave‐assisted diversified synthesis of pyrimidines: An overview

Journal Article
JOURNAL OF HETEROCYCLIC CHEMISTRY. Year: 2022. Volume: 59 , Issue: 2 , Pages: 205-238 .
Authors: Kapil Kumar
DOI 10.1002/jhet.4376 Crossref Crossref: 30 Scopus Scopus: 30

Kinase Inhibitors: A Promising Approach for Targeted Cancer Therapy

Journal Article
CHEMISTRY & BIODIVERSITY. Year: 2026. Volume: 23 , Issue: 4 , Pages: e03338 .
Authors: Vishakha Sharma; Ankush Kumar; Rajesh Gour; Kapil Kumar
DOI 10.1002/cbdv.202503338 Crossref Crossref: 1 Scopus Scopus: 2

Synthetic and Medicinal Perspective of 1,2,4‐Triazole as Anticancer Agents

Journal Article
CHEMISTRY & BIODIVERSITY. Year: 2022. Volume: 19 , Issue: 11 , Pages: e202200679 .
Authors: Bhagyashri Rathod; Kapil Kumar
DOI 10.1002/cbdv.202200679 Crossref Crossref: 37 Scopus Scopus: 36
Showing 1 to 8 of 55 publications